Literature DB >> 29351154

Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.

Raymond Addante1, Bruce Naliboff1, Wendy Shih2, Angela P Presson3, Kirsten Tillisch1, Emeran A Mayer1, Lin Chang1.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) reduces health-related quality of life (HRQOL). It is unclear how having IBS modifies the impact of gastrointestinal (GI), psychosocial, and somatic symptom variables on HRQOL compared with healthy controls (HCs). AIMS: (1) Determine psychosocial, somatic, and physical status variables most predictive of HRQOL in IBS and HCs and (2) determine if IBS status modifies relationships between predictive factors and HRQOL.
METHODS: IBS patients and HCs completed validated questionnaires measuring GI symptoms, psychosocial/somatic variables, and physical [physical component score (PCS)] and mental [mental component score (MCS)] HRQOL via the Short-Form-36. Associations between these variables and HRQOL were evaluated with multiple linear regressions. Variables were standardized to determine the strongest predictors of HRQOL. Statistical significance level was 0.01.
RESULTS: Mean HRQOL was higher in 417 HCs versus 290 IBS subjects (PCS: 55.6 vs. 48.6, P<0.001; MCS: 53.7 vs. 44.8, P<0.001). The GI symptom measures were negatively associated with PCS in IBS, but only usual severity was associated with MCS (P<0.01). In all subjects, psychosocial and somatic measures were associated with MCS and not PCS excluding GI symptom anxiety, which correlated with both (P<0.01). The strongest predictor of MCS was perceived stress in IBS and depression symptoms in HCs. GI symptom anxiety was the strongest predictor of PCS in both. Greater perceived stress and somatic symptom severity and less mindfulness was linked to larger reductions in HRQOL for IBS compared with HCs (P<0.01).
CONCLUSIONS: GI symptom severity and anxiety correlate with PCS, whereas psychosocial/somatic measures parallel MCS. However, HRQOL is comparable in IBS and HCs when perceived stress, somatic symptom severity, and mindfulness are at optimal levels. These findings may have important implications in the management of IBS.

Entities:  

Year:  2019        PMID: 29351154      PMCID: PMC6051929          DOI: 10.1097/MCG.0000000000000978

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  57 in total

1.  Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study.

Authors:  S L S Halder; G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Aliment Pharmacol Ther       Date:  2004-01-15       Impact factor: 8.171

2.  Validation of the Mindful Attention Awareness Scale in a cancer population.

Authors:  Linda E Carlson; Kirk Warren Brown
Journal:  J Psychosom Res       Date:  2005-01       Impact factor: 3.006

3.  The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

4.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population.

Authors:  D K Reibel; J M Greeson; G C Brainard; S Rosenzweig
Journal:  Gen Hosp Psychiatry       Date:  2001 Jul-Aug       Impact factor: 3.238

6.  Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.

Authors:  F Creed; J Ratcliffe; L Fernandez; B Tomenson; S Palmer; C Rigby; E Guthrie; N Read; D Thompson
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

7.  Irritable bowel syndrome in France: a common, debilitating and costly disorder.

Authors:  Michel Dapoigny; Jérôme Bellanger; Bruno Bonaz; Stanislas Bruley des Varannes; Lionel Bueno; Benoît Coffin; Philippe Ducrotté; Bernard Flourié; Marc Lémann; Anne Lepicard; Olivier Reigneau
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 2.566

8.  The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.

Authors:  J S Labus; R Bolus; L Chang; I Wiklund; J Naesdal; E A Mayer; B D Naliboff
Journal:  Aliment Pharmacol Ther       Date:  2004-07-01       Impact factor: 8.171

9.  Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.

Authors:  Brennan M R Spiegel; Ian M Gralnek; Roger Bolus; Lin Chang; Gareth S Dulai; Emeran A Mayer; Bruce Naliboff
Journal:  Arch Intern Med       Date:  2004-09-13

10.  Resource utilization associated with irritable bowel syndrome in the United States 1987-1997.

Authors:  Ya-Chen Tina Shih; Victoria E Barghout; Robert S Sandler; Priti Jhingran; Medha Sasane; Suzanne Cook; David C Gibbons; Michael Halpern
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

View more
  12 in total

1.  The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea.

Authors:  Aditi Kumar; Niall Galbraith; Hafid O Al-Hassi; Manushri Jain; Oliver Phipps; Jeffrey Butterworth; Helen Steed; John McLaughlin; Matthew J Brookes
Journal:  BMC Gastroenterol       Date:  2022-07-02       Impact factor: 2.847

2.  Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.

Authors:  Yasunori Yamamoto; Shinya Furukawa; Junichi Watanabe; Aki Kato; Katsunori Kusumoto; Teruki Miyake; Eiji Takeshita; Yoshio Ikeda; Naofumi Yamamoto; Yuka Saeki; Yoichi Hiasa
Journal:  Int J Colorectal Dis       Date:  2022-10-20       Impact factor: 2.796

Review 3.  The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia.

Authors:  Gerald A Higgins; Shaungsong Hong; John W Wiley
Journal:  Cell Mol Neurobiol       Date:  2021-05-31       Impact factor: 5.046

4.  A neuropsychosocial signature predicts longitudinal symptom changes in women with irritable bowel syndrome.

Authors:  Ravi R Bhatt; Arpana Gupta; Jennifer S Labus; Cathy Liu; Priten P Vora; Bruce D Naliboff; Emeran A Mayer
Journal:  Mol Psychiatry       Date:  2021-11-24       Impact factor: 13.437

5.  Associations of Abdominal Pain and Psychosocial Distress Measures With Health-Related Quality-of-Life in Pediatric Healthy Controls and Irritable Bowel Syndrome.

Authors:  John M Hollier; Danita I Czyzewski; Mariella M Self; Yan Liu; Erica M Weidler; Miranda A L van Tilburg; James W Varni; Robert J Shulman
Journal:  J Clin Gastroenterol       Date:  2021 May-Jun 01       Impact factor: 3.174

6.  The effects of locomotor activity on gastrointestinal symptoms of irritable bowel syndrome among younger people: An observational study.

Authors:  Toyohiro Hamaguchi; Jun Tayama; Makoto Suzuki; Naoki Nakaya; Hirokazu Takizawa; Kohei Koizumi; Yoshifumi Amano; Motoyori Kanazawa; Shin Fukudo
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

7.  The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.

Authors:  Xin Yao; Yunsheng Yang; Shutian Zhang; Yu Shi; Qian Zhang; Yongjun Wang
Journal:  BMC Gastroenterol       Date:  2020-07-06       Impact factor: 3.067

8.  Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.

Authors:  Zsa Zsa R M Weerts; Lisa Vork; Zlatan Mujagic; Daniel Keszthelyi; Martine A M Hesselink; Joanna Kruimel; Carsten Leue; Jean W M Muris; Daisy M A E Jonkers; Ad A M Masclee
Journal:  Neurogastroenterol Motil       Date:  2019-05-22       Impact factor: 3.598

Review 9.  Emerging wearable technology applications in gastroenterology: A review of the literature.

Authors:  Kimberly Pl Chong; Benjamin Kp Woo
Journal:  World J Gastroenterol       Date:  2021-03-28       Impact factor: 5.742

Review 10.  Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review.

Authors:  Sun Jung Oh; Will Takakura; Ali Rezaie
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.